You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Therapeutic HCV vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

Active, not recruiting
  • Chronic Hepatitis
  • Hepatitis C Infection
  • Electroporation-Mediated Plasmid DNA Vaccine Therapy
  • +4 more
  • Jacksonville, Florida
  • +4 more
Sep 20, 2022

HCV Infection Trial in Phnom Penh (Sofosbuvir/Daclatasvir)

Not yet recruiting
  • HCV Infection
  • Phnom Penh, Cambodia
    Clinical Trial Unit (Ctu)
Aug 7, 2023

Solid Tumor, Adult Trial in Beijing (Vaccine)

Not yet recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 3, 2023

HSIL of Cervix Trial in Heze (NWRD08)

Recruiting
  • HSIL of Cervix
  • NWRD08
  • Heze, Shandong, China
    Heze Municipal Hospital
Jun 6, 2023

Chronic Hepatitis C Infection Trial in Richmond (HCVax)

Recruiting
  • Chronic Hepatitis C Infection
  • HCVax
  • Richmond, Virginia
    Virginia Commonwealth University, Medical Center
Sep 28, 2021

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

Squamous Cell Carcinoma of Head and Neck Trial (0.5 mL Candin®/injection, Placebo: 0.5 mL Intravenous 0.9% NaCl solution

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • 0.5 mL Candin®/injection
  • Placebo: 0.5 mL Intravenous 0.9% NaCl solution (Saline)
  • (no location specified)
Jul 17, 2023

Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

Not yet recruiting
  • Advanced Ovarian Cancer
  • AST-201
  • +4 more
  • Seattle, Washington
    University of Washington
Mar 20, 2023

Chronic Hepatitis B Trial in Hamburg (HEPLISAV B; TherVacB, TherVacB)

Not yet recruiting
  • Chronic Hepatitis B
  • HEPLISAV B; TherVacB
  • TherVacB
  • Hamburg, Germany
    CTC North
Feb 3, 2023

Tumor Vaccines for Solid Tumors

Recruiting
  • Glioma
  • Solid Tumor
  • tumor vaccine
  • +3 more
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Oct 22, 2023

CIN3, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 3 Trial in Groningen (Vvax001 therapeutic

Recruiting
  • CIN3
  • +3 more
  • Vvax001 therapeutic cancer vaccine
  • Groningen, Netherlands
    University Medical Center Groningen (UMCG)
Aug 23, 2023

HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1

Not yet recruiting
  • HIV Vaccine
  • Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
  • +2 more
  • São Paulo, Brazil
    Hospital das Clínicas da Faculdade de Medicina da USP
Mar 14, 2023

Gastric Cancer Trial in Taiwan (AST-301, rhuGM-CSF)

Not yet recruiting
  • Gastric Cancer
  • Kaohsiung, Taiwan
  • +5 more
Mar 14, 2023

COVID-19, Therapeutic Vaccine, BCG Trial in Campinas (BCG, Placebo)

Active, not recruiting
  • COVID-19
  • +4 more
  • BCG
  • Placebo
  • Campinas, SP, Brazil
    Hospital das Clínicas Unicamp
Mar 23, 2022

High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8

Not yet recruiting
  • High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
  • +3 more
  • PD-L1/IDO Peptide Vaccine
  • Pembrolizumab
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Apr 24, 2023

Prostate Cancer Trial in Oslo (TENDU)

Recruiting
  • Prostate Cancer
  • TENDU
  • Oslo, Norway
    Oslo University Hospital, The Norwegian Radium Hospital
Mar 29, 2022

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous

Active, not recruiting
  • Malignant Neoplasms of Brain
  • tetanus toxoid
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Chronic Hepatitis b Trial in Adelaide (Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine)

Not yet recruiting
  • Chronic Hepatitis b
  • Therapeutic hepatitis B vaccine
  • Commercial Hepatitis B vaccine
  • Adelaide, South Australia, Australia
    Flinders University
Mar 7, 2022

Human Papilloma Virus, Warts, Warts, Genital Trial in San Francisco (nonavalent human papillomavirus vaccine)

Recruiting
  • Human Papilloma Virus
  • +4 more
  • nonavalent human papillomavirus vaccine
  • San Francisco, California
    Zuckerberg San Francisco General Hospital
May 20, 2022

Tuberculosis Trial in Bergen, Oslo (etoricoxib, H56:IC31)

Completed
  • Tuberculosis
  • Bergen, Norway
  • +1 more
Apr 7, 2022

Advanced Cancer Trial in Seoul (AST-021p)

Recruiting
  • Advanced Cancer
  • Seoul, Korea, Republic of
  • +2 more
Jul 20, 2022

Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep

Recruiting
  • Glioma, Malignant
  • +2 more
  • NeoPep Vaccine1 plus Poly-ICLC
  • NeoPep Vaccine2 plus Poly-ICLC
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 7, 2022

National Vaccine Adverse Event Reporting Survey and Etiology

Recruiting
  • COVID-19
  • +12 more
  • vaccinated
  • Northglenn, Colorado
    Neuroganics LLC
Mar 3, 2022

Genital Herpes Trial in United States (mRNA-1608, BEXSERO)

Recruiting
  • Genital Herpes
  • mRNA-1608
  • BEXSERO
  • Birmingham, Alabama
  • +24 more
Sep 11, 2023